Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jun;57(12):1475-1476.
doi: 10.1111/apt.17482.

Letter: practical considerations for nonselective beta-blocker therapy in portal hypertension

William Shanahan  1 , Maeve Clarke  1 , Eimear Carolan  1   2 , John D Ryan  1
Affiliations
Comment

Letter: practical considerations for nonselective beta-blocker therapy in portal hypertension

William Shanahan et al. Aliment Pharmacol Ther. 2023 Jun.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Gillespie S-L, Hanrahan TP, Rockey DC, Majumdar A, Hayes PC. Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis. Aliment Pharmacol Ther. 2023;57(5):454-63. https://doi.org/10.1111/apt.17380
    1. Villanueva C, Albillos A, Genescà J, Garcia-Pagan JC, Calleja JL, Aracil C, et al. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019;393(10181):1597-608. https://doi.org/10.1016/S0140-6736(18)31875-0
    1. McDowell HR, Chuah CS, Tripathi D, Stanley AJ, Forrest EH, Hayes PC. Carvedilol is associated with improved survival in patients with cirrhosis: a long-term follow-up study. Aliment Pharmacol Ther. 2021;53(4):531-9. https://doi.org/10.1111/apt.16189
    1. Dunne PDJ, Young D, Chuah CS, Hayes PC, Tripathi D, Leithead J, et al. Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding-long-term follow-up of a randomised control trial. Aliment Pharmacol Ther. 2022;55(12):1581-7. https://doi.org/10.1111/apt.16901
    1. Villanueva C, Torres F, Sarin SK, Shah HA, Tripathi D, Brujats A, et al. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. J Hepatol. 2022;77(4):1014-25. https://doi.org/10.1016/j.jhep.2022.05.021

MeSH terms

Substances